- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-SIA4C/ ST3GAL4/ CGS23 functional antibody
Anti-SIA4C/ ST3GAL4/ CGS23 functional antibody for cell culture, ELISA & in-vivo assay
Go to ST3GAL4/ST3GAL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0489-Ab-1/ GM-Tg-hg-SE0489-Ab-2 | Anti-Human ST3GAL4 monoclonal antibody | Human |
| GM-Tg-rg-SE0489-Ab-1/ GM-Tg-rg-SE0489-Ab-2 | Anti-Rat ST3GAL4 monoclonal antibody | Rat |
| GM-Tg-mg-SE0489-Ab-1/ GM-Tg-mg-SE0489-Ab-2 | Anti-Mouse ST3GAL4 monoclonal antibody | Mouse |
| GM-Tg-cynog-SE0489-Ab-1/ GM-Tg-cynog-SE0489-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ST3GAL4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0489-Ab-1/ GM-Tg-felg-SE0489-Ab-2 | Anti-Feline ST3GAL4 monoclonal antibody | Feline |
| GM-Tg-cang-SE0489-Ab-1/ GM-Tg-cang-SE0489-Ab-2 | Anti-Canine ST3GAL4 monoclonal antibody | Canine |
| GM-Tg-bovg-SE0489-Ab-1/ GM-Tg-bovg-SE0489-Ab-2 | Anti-Bovine ST3GAL4 monoclonal antibody | Bovine |
| GM-Tg-equg-SE0489-Ab-1/ GM-Tg-equg-SE0489-Ab-2 | Anti-Equine ST3GAL4 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE0489-Ab-1/ GM-Tg-hg-SE0489-Ab-2; GM-Tg-rg-SE0489-Ab-1/ GM-Tg-rg-SE0489-Ab-2; GM-Tg-mg-SE0489-Ab-1/ GM-Tg-mg-SE0489-Ab-2; GM-Tg-cynog-SE0489-Ab-1/ GM-Tg-cynog-SE0489-Ab-2; GM-Tg-felg-SE0489-Ab-1/ GM-Tg-felg-SE0489-Ab-2; GM-Tg-cang-SE0489-Ab-1/ GM-Tg-cang-SE0489-Ab-2; GM-Tg-bovg-SE0489-Ab-1/ GM-Tg-bovg-SE0489-Ab-2; GM-Tg-equg-SE0489-Ab-1/ GM-Tg-equg-SE0489-Ab-2 |
| Products Name | Anti-ST3GAL4 monoclonal antibody |
| Format | mab |
| Target Name | ST3GAL4 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-ST3GAL4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-SE0489-Ag-1 | Recombinant multi-species SIA4C/ ST3GAL4/ CGS23 protein |
| ORF Viral Vector | vGMLP003956 | human ST3GAL4 Lentivirus particle |
| ORF Viral Vector | pGMLP003956 | human ST3GAL4 Lentivirus plasmid |
| ORF Viral Vector | pGMLPm002291 | mouse St3gal4 Lentivirus plasmid |
| ORF Viral Vector | vGMLPm002291 | mouse St3gal4 Lentivirus particle |
Target information
| Target ID | GM-SE0489 |
| Target Name | ST3GAL4 |
| Gene ID | 6484,20443,363040,717792,607094,101089461,404163,100072459 |
| Gene Symbol and Synonyms | CGS23,gal-NAc6S,NANTA3,SAT3,SIAT4,SIAT4-C,SIAT4C,ST-4,ST3Gal IV,ST3GAL-IV,ST3GAL4,ST3GalA.2,ST3GalIV,STZ |
| Uniprot Accession | Q11206,P61131 |
| Uniprot Entry Name | SIA4C_HUMAN,SIA4C_RAT |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000110080 |
| Target Classification | N/A |
The target: ST3GAL4, gene name: ST3GAL4, also named as CGS23, NANTA3, SAT3, SIAT4, SIAT4C, ST-4, ST3GalA.2, ST3GalIV, STZ, gal-NAc6S. This gene encodes a member of the glycosyltransferase 29 family, a group of enzymes involved in protein glycosylation. The encoded protein is targeted to Golgi membranes but may be proteolytically processed and secreted. The gene product may also be involved in the increased expression of sialyl Lewis X antigen seen in inflammatory responses. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
